Signup/Login
If you want to receive notifications of upcoming IPOs, you need to simply sign up or sign in with social networks.
Signup/Login
Can you determine which companies are good and which ones - the trash?
Free Pro-version
IPO Filter
Monitor
IPO today
Upcoming IPO
Transcode Therapeutics (RNAZ)
Squarespace, Inc. (SQSP)
Procore Technologies, Inc. (PCOR)
Oatly Group Ab (OTLY)
Ziprecruiter, Inc. (ZIP)
Priced IPO
Save Foods (SVFD)
Vera Therapeutics, Inc. (VERA)
Digital Brands Group, Inc. (DBGI)
Ipower Inc. (IPW)
Global-e Online Ltd. (GLBE)
Similarweb Ltd. (SMWB)
Flora Growth (FLGC)
Anebulo Pharmaceuticals (ANEB)
Bowman Consulting Group Ltd. (BWMN)
Onion Global Limited (OG)
Waterdrop Inc. (WDH)
Talaris Therapeutics, Inc. (TALS)
Valneva Se (VALN)
Five Star Bancorp (FSBC)
The Honest Company Inc. (HNST)
Alfi, Inc. (ALF)
Red Cat Holdings (RCAT)
Werewolf Therapeutics Inc. (HOWL)
Vaccitech Plc. (VACC)
Endeavor Group Holdings (EDR)
More companies

Treace Medical Concepts, Inc. (TMCI)

Sector - Healthcare

Price chart

+73.53%
Return from IPO

Company News

IPO Profile

About company

Company Logo
They are a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgical treatment of Hallux Valgus (commonly known as bunions). They have pioneered their proprietary Lapiplasty 3D Bunion Correction System -- a combination of novel instruments, implants and surgical methods designed to improve the inconsistent clinical outcomes of traditional approaches to bunion surgery. Although bunions are deformities typically caused by an unstable joint in the middle of the foot that leads to a three-dimensional (3D) misalignment in the foot’s anatomical structure, the majority of traditional surgical approaches focus on correcting the deformity from a two-dimensional (2D) perspective and therefore fail to address the root cause of the disorder. To effectively restore the normal anatomy of bunion patients and improve clinical outcomes, they believe addressing the root cause of the bunion is critical and have developed the Lapiplasty System to correct the deformity across all three anatomic dimensions. Their mission is to be the leader in the surgical treatment of bunions by establishing the Lapiplasty System as the standard of care.
Industry
Surgical & Medical Instruments & Apparatus
CEO CFO
John T. Treace Mark L. Hair
Employees Founded
133 2014

Contacts

Address: 203 Fort Wade Rd., Suite 150 Ponte Vedra, Florida 32081

Telephone: (904) 373-5940

Web page: http://www.treace.com

IPO information

First Trade Date 4/23/2021
Status Priced
Exchange NASDAQ
Lockup Period Expiration .Pro
Quiet Period Expiration .Pro
Old Price Range
-
Share prices ($)

Shares & Volumes

Shares Initial (MM) 9.38
Shares Revised (MM) 11.25
Expected offer amount (MM) $150
Realized offer amount(MM) $191.25

Financial Data (last reporting year)

Market Cap (MM) $807.36
Revenues (MM) $57.37
Net Income (Loss) (MM) $-4.31

Voting

What do you think will happen with the TMCI share price after the next 3-6 months? 🔥 (+ 10% or more, flat (+ -10%), -10% or less)

Number of votes: img
The lead left underwriter: JP Morgan

IPOs led by the firm .Pro
Profitability of conducted IPOs  ?  .Pro
1st day change  ?  .Pro
Change for the first 3 months  ?  .Pro
Underwriters
JP Morgan/ Morgan Stanley
CO-Managers
SVB Leerink/ Stifel

Sector: Healthcare

Tweets about $TMCI

Tweets volume:

RT volume:

Timeframe:

Google Trends Stats